Wednesday, August 26, 2009

More on Cipla, Plumpy'Nut and India

Stephanie Nolan, the South Asia Correspondent for Canada's Globe and Mail, and I have been corresponding on Twitter about the goings on in India with respect to Plumpy'Nut, RUTFs and official government policy. As part of an article she wrote about the Plumpy'Nut controversy in India, she says, she tried to find out exactly what the Cipla product is and whether it's equivalent to Plumpy'Nut and got ten different answers.

Today she writes that "further invstigation shows Cipla product, whatever is, not WHO-approved & not officially RUTF. Delhi-based Compact closest 2 making."

Related post: India, Plumpy'Nut and Cipla
Related posts on Plumpy'Nut patent issues under intellectual property tag.

1 comment:

Ask A Doctor said...

This is not new with regards to India where drugs that are banned for use even on the animals in Us are being openly marketed and used on the general public.